![Mark Watson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Watson
Direttore/Membro del Consiglio presso
ABRDN HEALTHCARE OPPORTUNITIES FUND
Profilo
Mark Watson is currently the Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc. since 2009.
He is also currently serving as an Independent Trustee at abrdn Healthcare Opportunities Fund starting in 2022.
Previously, Mr. Watson held positions as Director at Sykes Enterprises, Inc. from 2018 to 2021, Director at BioDelivery Sciences International, Inc. from 2017 to 2022, and Director at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Posizioni attive di Mark Watson
| Società | Posizione | Inizio |
|---|---|---|
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Direttore/Membro del Consiglio | 09/06/2022 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Direttore/Membro del Consiglio | 01/01/2009 |
Precedenti posizioni note di Mark Watson
| Società | Posizione | Fine |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 13/12/2022 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direttore/Membro del Consiglio | 02/01/2022 |
| SYKES ENTERPRISES, INCORPORATED | Direttore/Membro del Consiglio | 02/01/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
52
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Sykes Enterprises, Inc.
 Sykes Enterprises, Inc. Information Technology ServicesTechnology Services Provides business process outsourcing services | Technology Services |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Commercial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
